Exciting drug developments in chronic lymphocytic leukemia (CLL)
Results of CheckMate 039 trial of nivolumab in combination with ipilimumab for Hodgkin lymphoma
BCR inhibitors improving CLL patient outcomes
From chemotherapy towards targeted therapies in CLL
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.